The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
Open accessAbstract
Rationale: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology with a variable and unpredictable course. Objectives: The aim of this study was to identify and validate plasma proteins that are predictive of outcome in IPF. Methods: Plasma samples were available for 241 patients with IPF (140 derivation and 101 validation). In the derivation cohort, concentrations of 92 proteins were analyzed using a multiplex bead-based immunoassay and concentrations of matrix metalloproteinase (MMP)-7, MMP-1, and surfactant protein D were assessed by ELISA. In the validation cohort concentrations of intercellular adhesion molecule (ICAM)-1, IL-8, and vascular cell adhesion molecule (VCAM)-1 were assessed by bead-based multiplex assay, and S100A12 and MMP-7 by ELISA. Associations of biomarkers with mortality, transplant-free survival, and disease progression were tested in the derivation and validation cohorts using nonparametric methods of survival analysis and the Cox proportional hazards model, and an integrated risk prediction score was derived and tested. Measurements and Main Results: High concentrations of MMP-7, ICAM-1, IL-8, VCAM-1, and S100A12 predicted poor overall survival, poor transplant-free survival, and poor progression-free survival in the derivation cohort. In the independent validation cohort high concentrations of all five were predictive of poor transplant-free survival; MMP-7, ICAM-1, and IL-8 of overall survival; and ICAM-1 of poor progression-free survival. The personal clinical and molecular mortality prediction index derived in the derivation cohort was highly predictive of mortality in the validation cohort. Conclusions: Our results suggest that plasma proteins should be evaluated as a tool for prognosis determination in prioritization of patients for lung transplantation and stratification in drug studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High plasma concentrations of MMP7, vascular cell adhesion molecule (VCAM)-1, S100A12, intercellular adhesion molecule (ICAM)1, and IL-8 predicted poor overall survival, transplant-free survival, and progression-free survival in an IPF derivation cohort of 141 patients, while all five were predictive of poor transplant-free survival; MMP7, ICAM-1, and IL-8 of over”
From Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies (2023) · cites this paper as Richards et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statisctics and computing/Statistics and computing · doi:10.1007/978-0-387-21706-2 · Cited by 25,941
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
Krämer, W. (2003) · Computational Statistics & Data Analysis · Cited by 1,858
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,807
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Uno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535
Willis, B. C., Liebler, J. M., Luby‐Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 973
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Cited by
Sorted by citations
Items 101–200 of 383
Wu, A. C., Kiley, J. P., Noel, P. J., Amur, S., Burchard, E. G., Clancy, J. P., Galanter, J., Inada, M., Jones, T. K., Kropski, J. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1895st · Cited by 69
Helling, B. A., & Yang, I. V. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000191 · Cited by 66
Li, Y., He, Y., Chen, S., Wang, Q., Yang, Y., Shen, D., Ma, J., Wen, Z., Ning, S., & Chen, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.810338 · Cited by 65
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis
Sokai, A., Handa, T., Tanizawa, K., Oga, T., Uno, K., Tsuruyama, T., Kubo, T., Ikezoe, K., Nakatsuka, Y., Tanimura, K., et al. (2015) · Respiratory Research · doi:10.1186/s12931-015-0280-9 · Cited by 64
The Red Cell Distribution Width as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis
Nathan, S. D., Reffett, T., Brown, A. W., Fischer, C. P., Shlobin, O. A., Ahmad, S., Weir, N. A., & Sheridan, M. J. (2012) · CHEST Journal · doi:10.1378/chest.12-1368 · Cited by 64
O’Dwyer, D. N., Norman, K. C., Xia, M., Huang, Y., Gurczynski, S. J., Ashley, S. L., White, E. S., Flaherty, K. R., Martínez, F. J., Murray, S., et al. (2017) · Scientific Reports · doi:10.1038/srep46560 · Cited by 65
Kim, J. S., Podolanczuk, A. J., Borker, P. V., Kawut, S. M., Raghu, G., Kaufman, J. D., Stukovsky, K. H., Hoffman, E. A., Barr, R. G., Gottlieb, D. J., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-091oc · Cited by 66
Idiopathic pulmonary fibrosis and a role for autoimmunity
Hoyne, G. F., Elliott, H., Mutsaers, S. E., & Prêle, C. M. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.22 · Cited by 68
Neutrophils as critical orchestrators of chronic inflammation
Torfs, K., Vermeersch, G., Gouwy, M., Devos, T., Proost, P., & Struyf, S. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01380-w · Cited by 79
Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to Treatment
Maher, T. M. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.11.002 · Cited by 65
Khan, F., Stewart, I. D., Saini, G., Robinson, K. A., & Jenkins, G. R. (2021) · European Respiratory Journal · doi:10.1183/13993003.01612-2021 · Cited by 60
Bennett, D., Fossi, A., Bargagli, E., Refini, R. M., Pieroni, M., Luzzi, L., Ghiribelli, C., Paladini, P., Voltolini, L., & Rottoli, P. (2015) · Lung · doi:10.1007/s00408-015-9767-x · Cited by 58
Lindell, K. O., Klein, S. J., Veatch, M. S., Gibson, K. F., Kass, D. J., Nouraie, M. S., & Rosenzweig, M. Q. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202012-1494oc · Cited by 62
Self-citationPulmonary fibrosis: Emerging diagnostic and therapeutic strategies
Selvarajah, B., Platé, M., & Chambers, R. C. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101227 · Cited by 57
Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis
Vukmirovic, M., & Kaminski, N. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00087 · Cited by 56
Self-citationMucins as a New Frontier in Pulmonary Fibrosis
Ballester, B., Milara, J., & Cortijo, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091447 · Cited by 59
Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis
Afratis, N. A., Selman, M., Pardo, A., & Sagi, I. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.007 · Cited by 56
Hambly, N., Shimbori, C., & Kolb, M. R. J. (2015) · Respirology · doi:10.1111/resp.12569 · Cited by 60
Fibulin-1 Predicts Disease Progression in Patients With Idiopathic Pulmonary Fibrosis
Jaffar, J., Unger, S., Corte, T. J., Keller, M., Wolters, P. J., Richeldi, L., Cerri, S., Prêle, C. M., Hansbro, P. M., Argraves, W. S., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2688 · Cited by 55
Idiopathic Pulmonary Fibrosis: Diagnosis and Prognostic Evaluation
Poletti, V. E., Ravaglia, C., Buccioli, M., Tantalocco, P., Piciucchi, S., Dubini, A., Carloni, A., Chilosi, M., & Tomassetti, S. (2013) · Respiration · doi:10.1159/000353580 · Cited by 53
Tomos, I. P., Tzouvelekis, A., Aidinis, V., Manali, E. D., Bouros, E., Bouros, D. E., & Papiris, S. A. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1300533 · Cited by 52
Lefere, S., de Velde, F. V., Devisscher, L., Bekaert, M., Raevens, S., Verhelst, X., Nieuwenhove, Y. V., Praet, M. M., Hoorens, A., Steenkiste, C. V., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.102 · Cited by 53
Fibrosis: Lessons from OMICS analyses of the human lung
Yu, G., Ibarra, G. H., & Kaminski, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.014 · Cited by 52
Self-citationCirculating Plasma Biomarkers of Progressive Interstitial Lung Disease
Alqalyoobi, S., Adegunsoye, A., Linderholm, A., Hrusch, C. L., Cutting, C. C., Ma, S., Sperling, A. I., Noth, I., Strek, M. E., & Oldham, J. M. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1343le · Cited by 53
Recent advances in rheumatoid arthritis-associated interstitial lung disease
Juge, P., Crestani, B., & Dieudé, P. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000710 · Cited by 52
Zou, R. H., Kass, D. J., Gibson, K. F., & Lindell, K. O. (2020) · Pulmonary Therapy · doi:10.1007/s41030-019-00108-2 · Cited by 53
Self-citationLee, S. H., Park, J. S., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Park, S. W., Jeong, S. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23073-3 · Cited by 50
Molecular Signatures of Idiopathic Pulmonary Fibrosis
Konigsberg, I. R., Borie, R., Walts, A. D., Cardwell, J., Rojas, M., Metzger, F., Hauck, S. M., Fingerlin, T. E., Yang, I. V., & Schwartz, D. A. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0546oc · Cited by 52
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis
Zhao, A., Unterman, A., Hussein, N. S. A., Sharma, P., Nikola, F., Flint, J., Yan, X., Adams, T. S., Justet, A., Sumida, T. S., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0078oc · Cited by 52
Self-citationPeng, X., Moore, M. W., Peng, H., Sun, H., Gan, Y., Homer, R., & Herzog, E. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00080 · Cited by 47
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study
Podolanczuk, A. J., Raghu, G., Tsai, M. Y., Kawut, S. M., Peterson, E. R., Sonti, R., Rabinowitz, D., Johnson, C. W., Barr, R. G., Stukovsky, K. H., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209568 · Cited by 49
Richards, T. J., Park, C., Chen, Y., Gibson, K. F., Di, Y. P., Pardo, A., Watkins, S. C., Choi, A. M. K., Selman, M., Pilewski, J. M., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00319.2011 · Cited by 48
Self-citationBehera, S. K., Praharaj, A. B., Dehury, B., & Negi, S. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9606-6 · Cited by 47
Identification of Helicobacter pylori VacA in human lung and its effects on lung cells
Nakashima, S., Kakugawa, T., Yura, H., Tomonaga, M., Harada, T., Hara, A., Hara, S., Nakano, M., Yamasaki, E., Sakamoto, N., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.096 · Cited by 47
iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis
Niu, R. L., Liu, Y., Zhang, Y., Zhang, Y., Wang, H., Wang, Y., Wang, W., & Li, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170741 · Cited by 46
Self-citationArmstrong, H. F., Podolanczuk, A. J., Barr, R. G., Oelsner, E. C., Kawut, S. M., Hoffman, E. A., Tracy, R. P., Kaminski, N., McClelland, R. L., & Lederer, D. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0254oc · Cited by 47
Self-citationInterstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
Rosas, I. O., Dellaripa, P. F., Lederer, D. J., Khanna, D., Young, L. R., & Martínez, F. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-429ld · Cited by 46
Personalized medicine in idiopathic pulmonary fibrosis
Spagnolo, P., Τzouvelekis, Α., & Maher, T. M. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000187 · Cited by 48
Li, H.-H., Liu, C.-C., Hsu, T.-W., Lin, J.-H., Hsu, J., Li, A. F., Yeh, Y., Hung, S., & Hsu, H. (2021) · Particle and Fibre Toxicology · doi:10.1186/s12989-021-00404-3 · Cited by 50
Blandinières, A., Gendron, N., Bacha, N. C., Bièche, I., Chocron, R., Nunès, H., Névo, N., Rossi, E., Crestani, B., Lecourt, S., et al. (2019) · Angiogenesis · doi:10.1007/s10456-018-09659-5 · Cited by 44
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives
Crowley, L., Stockley, R. A., THICKETT, D. R., Dosanjh, D. P. S., Scott, A., & Parekh, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0139-2024 · Cited by 43
Liang, Z., Hoffman, L. A., Nouraie, M. S., Kass, D. J., Donahoe, M. P., Gibson, K. F., Saul, M. I., & Lindell, K. O. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0258 · Cited by 42
Self-citationPlasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Manichaikul, A. W., Sun, L., Borczuk, A., Önengüt-Gümüşcü, S., Farber, E., Mathai, S. K., Zhang, W., Raghu, G., Kaufman, J. D., Stukovsky, K. H., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-485oc · Cited by 43
T2 mapping of CT remodelling patterns in interstitial lung disease
Wetscherek, M. T., Eichinger, M., Kreuter, M., Kauczor, H., Herth, F. J. F., Warth, A., Pop, C. M., Heußel, C. P., & Dinkel, J. (2015) · European Radiology · doi:10.1007/s00330-015-3751-y · Cited by 41
Fließer, E., Jandl, K., Lins, T., Birnhuber, A., Valzano, F., Kolb, D., Foris, V., Heinemann, Á., Olschewski, H., Evermann, M., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0046oc · Cited by 40
Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings
Renzoni, E. A., Veeraraghavan, S., & Sestini, P. (2014) · F1000Prime Reports · doi:10.12703/p6-69 · Cited by 46
Lee, S. H., Yeo, Y., Kim, T., Lee, H. L., Lee, J. H., Park, Y. B., Park, J. S., Kim, Y. H., Song, J. W., Jhun, B. W., et al. (2019) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2018.0091 · Cited by 41
Identification of a Novel HIF-1α-αMβ2 Integrin-NET Axis in Fibrotic Interstitial Lung Disease
Khawaja, A. A., Chong, D. L. W., Sahota, J., Mikolasch, T., Pericleous, C., Ripoll, V. M., Booth, H., Khan, S., Rodriguez‐Justo, M., Giles, I., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02190 · Cited by 40
Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
Aversa, Z., Atkinson, E. J., Carmona, E. M., White, T. A., Heeren, A. A., Jachim, S. K., Zhang, X., Cummings, S. R., Chiarella, S. E., LIMPER, A. H., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02403-8 · Cited by 41
Kuller, L. H., Mackey, R. H., Walitt, B. T., Deane, K. D., Holers, V. M., Robinson, W. H., Sokolove, J. B., Chang, Y., Liu, S., Parks, C. G., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38268 · Cited by 37
Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis
Inchingolo, R., Varone, F., Sgalla, G., & Richeldi, L. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1553620 · Cited by 37
Li, X., Cai, H., Cai, Y., Zhang, Q., Ding, Y., & Zhuang, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629854 · Cited by 37
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
Ick, S., Ryerson, C. J., Lee, J. S., Kukreja, J., Barry, S. S., Jones, K. D., Elicker, B. M., Kim, D. S., Papa, F. R., Collard, H. R., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-105 · Cited by 38
Lindell, K. O., Nouraie, M. S., Klesen, M. J., Klein, S. J., Gibson, K. F., Kass, D. J., & Rosenzweig, M. Q. (2018) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000272 · Cited by 37
Self-citationRuan, P., Todd, J. L., Zhao, H., Liu, Y., Vinisko, R., Söllner, J. F., Schmid, R., Kaner, R. J., Luckhardt, T., Neely, M. L., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02435-0 · Cited by 43
Pennathur, S., Vivekanandan-Giri, A., Locy, M. L., Kulkarni, T., Zhi, D., Zeng, L., Byun, J., de Andrade, J. A., & Thannickal, V. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0992oc · Cited by 36
Jaffar, J., Wong, M., Fishbein, G. A., Alhamdoosh, M., McMillan, L., Gamell, C., Ng, M., Wilson, N. S., Symons, K., Glaspole, I., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00191-2022 · Cited by 35
Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis
Wang, S., Rao, W. H., Hoffman, A., Lin, J. M., Li, J., Lin, T., Liew, A.-A., Vincent, M., Mertens, T. C. J., Karmouty‐Quintana, H., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abp9528 · Cited by 35
Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
Nakamura, Y., & Suda, T. (2015) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.4137/ccrpm.s39897 · Cited by 40
The Expanding Role of Biomarkers in the Assessment of Smoking-Related Parenchymal Lung Diseases
Doyle, T. J., Pinto-Plata, V., Morse, D., Celli, B. R., & Rosas, I. O. (2012) · CHEST Journal · doi:10.1378/chest.12-1540 · Cited by 35
Zhang, Y., Li, X., & Di, Y. P. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0223-2_6 · Cited by 34
Self-citationSaunders, P. T., Toshner, R., & Maher, T. M. (2018) · doi:10.1201/9781315113807-52 · Cited by 32
Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
Tomos, I. P., Roussis, I., Matthaiou, A. Μ., & Dimakou, K. (2023) · Biomedicines · doi:10.3390/biomedicines11102796 · Cited by 35
Qian, W., Xia, S., Yang, X., Yu, J., Guo, B., Lin, Z., Wei, R., Mao, M., Zhang, Z., Zhao, G., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.800747 · Cited by 31
Onishchenko, D., Marlowe, R. J., Ngufor, C. G., Faust, L. J., LIMPER, A. H., Hunninghake, G. M., Martínez, F. J., & Chattopadhyay, I. (2022) · Nature Medicine · doi:10.1038/s41591-022-02010-y · Cited by 34
The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease
Karampitsakos, Τ., Tourki, B., & Herazo‐Maya, J. D. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.10.042 · Cited by 31
Russo, R. C., & Ryffel, B. (2024) · Cells · doi:10.3390/cells13242058 · Cited by 35
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
Clarke, D. L., Murray, L. A., Crestani, B., & Sleeman, M. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.010 · Cited by 31
Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
Lorenzo-Salazar, J. M., Ma, S., Jou, J., Hou, P., Guillén‐Guío, B., Allen, R. J., Jenkins, G. R., Wain, L. V., Oldham, J. M., Noth, I., et al. (2019) · ERJ Open Research · doi:10.1183/23120541.00071-2019 · Cited by 31
Maher, T. M. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328363f4b7 · Cited by 32
Murray, L. A., Rubinowitz, A. N., & Herzog, E. L. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283588de4 · Cited by 29
McGroder, C. F., Pistenmaa, C. L., Bielinski, S. J., Kawut, S. M., Tracy, R. P., Raghu, G., Barr, R. G., Lederer, D. J., & Podolanczuk, A. J. (2019) · European Respiratory Journal · doi:10.1183/13993003.00295-2019 · Cited by 29
The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?
Fließer, E., Lins, T., Berg, J. L., Kolb, M. R. J., & Kwapiszewska, G. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00097.2023 · Cited by 33
Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis
O’Dwyer, D. N., Armstrong, M. E., Kooblall, M., & Donnelly, S. C. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.988706 · Cited by 29
Pulmonary Aptamer Signatures in Children’s Interstitial and Diffuse Lung Disease
Deterding, R. R., Wagner, B. D., Harris, J. K., & DeBoer, E. M. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0547oc · Cited by 27
Wang, H., Zhuang, Y., Peng, H., Cao, M., Li, Y., Xu, Q., Xin, X., Zhou, K., Liang, G., Cai, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51902-6 · Cited by 25
Facts and promises on lung biomarkers in interstitial lung diseases
Campo, I., Zorzetto, M., & Bonella, F. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.1062367 · Cited by 25
Personalized Medicine in Respiratory Disease
Priyadharshini, V. S., & Teran, L. M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.008 · Cited by 27
The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?
Perkins, T. N., & Oury, T. D. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666211016071 · Cited by 25
Bahudhanapati, H., Tan, J., Apel, R. M., Seeliger, B., Schupp, J. C., Li, X., Sullivan, D. I., Sembrat, J., Rojas, M. M., Tabib, T., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00088-2023 · Cited by 26
Self-citationMagnini, D., Montemurro, G., Iovene, B., Tagliaboschi, L., Gerardi, R. E., Greco, E. L., Bruni, T., Fabbrizzi, A., Lombardi, F., & Richeldi, L. (2017) · Respiration · doi:10.1159/000475780 · Cited by 25
Respiratory Proteomics: From Descriptive Studies to Personalized Medicine
Teran, L. M., Montes‐Vizuet, R., Li, X., & Franz, T. (2014) · Journal of Proteome Research · doi:10.1021/pr500935s · Cited by 24
Personalized Medicine: Applying ‘omics’ to Lung Fibrosis
Herazo‐Maya, J. D., & Kaminski, N. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.38 · Cited by 24
Self-citationClassification of Diffuse Lung Diseases: Why and How
Hansell, D. M. (2013) · Radiology · doi:10.1148/radiol.13120908 · Cited by 24
Guidelines for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis
Xaubet, A., Ancochea, J., Bollo, E., Fernández‐Fabrellas, E., Franquet, T., Molina‐Molina, M., Montero, M. A., & Serrano‐Mollar, A. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2013.06.003 · Cited by 24
Oliveira, A. C. D. S., Fu, C., Lu, Y., Williams, M. A., Pi, L., Brantly, M., Ventetuolo, C. E., Raizada, M. K., Mehrad, B., Scott, E. W., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00156.2019 · Cited by 23
Biomarkers in Interstitial lung diseases
Nathan, N., Corvol, H., Amselem, S., & Clément, A. (2015) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2015.05.002 · Cited by 24
Okuda, R., Matsushima, H., Aoshiba, K., Oba, T., Kawabe, R., Honda, K., & Amano, M. (2015) · SpringerPlus · doi:10.1186/s40064-015-1455-z · Cited by 24
Risk Prediction in Idiopathic Pulmonary Fibrosis
Ley, B., & Collard, H. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-1960ed · Cited by 24
S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension
Tzouvelekis, A., Herazo‐Maya, J. D., Ryu, C., Chu, J., Zhang, Y., Gibson, K. F., Adonteng-Boateng, P., Li, Q., Pan, H., Cherry, B. M., et al. (2018) · Respirology · doi:10.1111/resp.13302 · Cited by 23
Self-citationBlood KL-6 predicts prognosis in primary Sjögren’s syndrome-associated interstitial lung disease
Kim, Y. J., Choe, J., Moon, S., & Song, J. W. (2022) · Scientific Reports · doi:10.1038/s41598-022-09283-w · Cited by 24
Guidelines for the selection of lung-transplant candidates
Shah, P. D., & Orens, J. B. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328357d898 · Cited by 23
Fernandez, I. E., Heinzelmann, K., Verleden, S. E., & Eickelberg, O. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201410-476mg · Cited by 23
Fernandez, I. E., Amarie, O. V., Mutze, K., Königshoff, M., Yildirim, A. Ö., & Eickelberg, O. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00183.2015 · Cited by 24
Personalised medicine in interstitial lung diseases
Kokosi, M. A., Margaritopoulos, G. A., & Wells, A. U. (2018) · European Respiratory Review · doi:10.1183/16000617.0117-2017 · Cited by 23
Novel insight into the genetic basis of high-altitude pulmonary hypertension in Kyrgyz highlanders
Iranmehr, A., Stobdan, T., Zhou, D., Poulsen, O., Strohl, K. P., Aldashev, A. A., Telenti, A., Wong, E., Kirkness, E. F., Venter, J. C., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0270-8 · Cited by 21
Jönsson, Å. L. M., Hilberg, O., Bendstrup, E. M., Mogensen, S., & Simonsen, U. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.185.4.464 · Cited by 22
Post‐translational regulation of PGC‐1α modulates fibrotic repair
Larson‐Casey, J. L., Gu, L., Davis, D., Cai, G., Ding, Q., He, C., & Carter, A. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100339r · Cited by 21
Moon, J., Lee, J. S., Yoon, Y. I., Chang, S. H., Lee, Y. A., Ha, Y., Kang, E. H., Park, Y., Lee, H., Choe, J., et al. (2021) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2021.28.4.234 · Cited by 21
Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
Drakopanagiotakis, F., Markart, P., & Steiropoulos, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210196 · Cited by 21
Metadata
- Authors
- Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., Klesen, M., Zhang, Y., & Gibson, K. F.
- Affiliations
- University of Pittsburgh (US)
- Centocor R&D Inc., Radnor, Pennsylvania
- Corresponding author
- Gibson, Kevin F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 185
- Issue
- 1
- Pages
- 67-76
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3262037
- OpenAlex
- W2007414618
- Cited by
- 381
- References
- 67
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 18 · 2023: 26 · 2022: 20 · 2021: 23 · 2020: 27 · 2019: 22 · 2018: 31 · 2017: 30 · 2016: 27 · 2015: 40 · 2014: 30 · 2013: 35 · 2012: 28
- FWCI
- 25.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P50 HL0894932, R01HL095397)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- idiopathic pulmonary fibrosis, plasma biomarkers, mortality prediction, MMP-7, ICAM-1, interleukin-8, VCAM-1, S100A12, surfactant protein D, transplant-free survival, progression-free survival, risk scoring, disease progression
- MeSH terms
- S100A12 Protein, Aged, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, S100 Proteins, Predictive Value of Tests, Cohort Studies, Biomarkers, Cell Adhesion Molecules, Proportional Hazards Models, Survival Analysis, Interleukin-8, Intercellular Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, Matrix Metalloproteinase 1, Matrix Metalloproteinases, Matrix Metalloproteinase 7, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
